Filing Flows › Teva Pharmaceutical Industries (TEVA) › Q2 2026
Teva Pharmaceutical Industries (TEVA) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 29, 2026
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.1B for the second quarter 2026 (Q2 2026), -0.8% from a year earlier and +4% from the quarter before. Operating margin was -5.6%, net loss $575M (13.9% of revenue).
Teva Pharmaceutical Industries, Q2 2026: revenue $4.1B (-0.8% year over year), operating margin -5.6%, net loss $575M, operating cash flow $411M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.1B | +4% | -0.8% |
| Operating profit | −$231M | -135% | -151% |
| Net earnings | −$575M | -256% | -304% |
| Operating cash flow | $411M | — | +81% |
| Free cash flow | $307M | — | +134% |
What changed
Revenue was $4.1B in Q2 2026, down 1% year over year and up 4% from the previous quarter. Product was the largest line at 87% of revenue. Product and Service Other lost $0.05B year over year (down 40%), 138% of the total change.
Gross margin was 52.0%, up 1.6 points from Q2 2025. Operating costs exceeded revenue by $0.23B, an operating margin of -5.6%. Operating expenses grew 45% against a revenue fall of 1%. The fastest-growing cost line was Research & development (+298%). The quarter ended with a net loss of $0.57B, after a profit of $0.37B the previous quarter.
Operating cash flow was $0.41B (up 81% year over year). Non-cash charges added back $0.24B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items added $0.70B. Capital expenditures of $0.10B left free cash flow of $0.31B.
Questions
What was Teva Pharmaceutical Industries' revenue in the second quarter 2026?
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.1B for the second quarter 2026 (Q2 2026), -0.8% from a year earlier and +4% from the quarter before.
Was Teva Pharmaceutical Industries profitable in the second quarter 2026?
Operating loss was $231M (-5.6% of revenue) and net loss $575M.